Aberrant promoter hypermethylation of multiple genes in head and neck squamous cell carcinoma.
about
Epigenetic diet: impact on the epigenome and cancerRecurrence in oral and pharyngeal cancer is associated with quantitative MGMT promoter methylationPolymorphisms of the DNA repair gene MGMT and risk and progression of head and neck cancer.Promoter hypermethylation of CDKN2A, MGMT, MLH1, and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients.Alcohol, DNA methylation, and cancerAlcohol consumption in relation to aberrant DNA methylation in breast tumorsQuantitative methodology is critical for assessing DNA methylation and impacts on correlation with patient outcomeDNA methylation changes associated with risk factors in tumors of the upper aerodigestive tractDifferences between oral cancer and cancers of the pharynx and larynx on a molecular levelIdentification of methylation markers for the prediction of nodal metastasis in oral and oropharyngeal squamous cell carcinomaQuantitative methylation analyses of resection margins predict local recurrences and disease-specific deaths in patients with head and neck squamous cell carcinomas.Identification of an epigenetic profile classifier that is associated with survival in head and neck cancer.Circadian disruption: potential implications in inflammatory and metabolic diseases associated with alcohol.DNA hypermethylation as an epigenetic mark for oral cancer diagnosis.DNA methylation in oral squamous cell carcinoma: molecular mechanisms and clinical implications.New Concepts for Translational Head and Neck Oncology: Lessons from HPV-Related Oropharyngeal Squamous Cell CarcinomasRole of DNA methylation in head and neck cancer.Environmental toxicants--induced epigenetic alterations and their reversers.Impaired one carbon metabolism and DNA methylation in alcohol toxicity.Histone modifications: Targeting head and neck cancer stem cells.Copy number profiling of tumor suppressor genes in head and neck cancer.Tumor suppressor p16(INK4A)/Cdkn2a alterations in 7, 12-dimethylbenz(a)anthracene (DMBA)-induced hamster cheek pouch tumors.Metabolic Phase I (CYPs) and Phase II (GSTs) Gene Polymorphisms and Their Interaction with Environmental Factors in Nasopharyngeal Cancer from the Ethnic Population of Northeast India.hMLH1 immunoexpression is related to the degree of epithelial dysplasia in oral leukoplakia.Aberrant DNA methylation of the p16, APC, MGMT, TIMP3 and CDH1 gene promoters in tumours and the surgical margins of patients with oral cavity cancer.
P2860
Q27022002-64A89283-EF6C-48B3-ACA4-2189A3C0A144Q33508931-C3C78594-9416-460D-8EA2-6A95B26D44E9Q33904061-BCC12D24-9932-4366-A09B-353573B1F91EQ34353796-824BD9E3-9933-4167-8A14-52AFEF28AA63Q34390179-87440D0C-EAF3-4F9B-A6BF-CB82B667A3AFQ35109249-68655D67-6AC2-4C0E-8B37-75B1F965A6DEQ35341665-D92A26BF-2795-4392-A490-5970BC7DC44AQ35911261-798ADB48-AA16-4267-B528-93202361297DQ35995516-F3722234-B52D-499B-B43A-3864E7A705ACQ36216177-974BDCB6-C7D8-45DA-B72D-A89A82CF311CQ36785987-5B044B61-48EA-4833-AA8B-26296888F371Q36833387-779CAD80-00F9-430F-9AC0-26ABCCB8769CQ37386428-7C43E022-06FC-4BB9-9DE0-22B2C57CB12EQ37886046-424E869C-A147-40E5-9E1B-77C65FFB9EDBQ37903920-AEF3D822-4BDE-47AC-BBAC-0123A6F2DAB3Q38015390-8D00827A-F806-4D56-A562-1260FD4186A5Q38019157-B921A771-3D5A-4BAE-8A3E-E1982EEE997FQ38061183-C42F1455-9736-4E4A-A04D-646BC32E9C5DQ38187459-EC460289-0EB0-4546-A5FB-304FCD66FA7CQ38271597-8D2E413C-1883-4FC5-BC2A-8239E2F225C8Q39328328-CB6938CC-CF15-4A22-9D5C-6A34638A1134Q41977782-99D08C93-8811-4BFB-936F-FDE426264077Q49797186-4078E978-655F-4F6A-BF42-96031B648525Q53294155-7BB8DFB2-7A75-43E5-8352-BDA0FC682AAAQ55306568-EF89CA08-8E41-4EDF-A63B-55D9C81DD79E
P2860
Aberrant promoter hypermethylation of multiple genes in head and neck squamous cell carcinoma.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Aberrant promoter hypermethyla ...... neck squamous cell carcinoma.
@ast
Aberrant promoter hypermethyla ...... neck squamous cell carcinoma.
@en
type
label
Aberrant promoter hypermethyla ...... neck squamous cell carcinoma.
@ast
Aberrant promoter hypermethyla ...... neck squamous cell carcinoma.
@en
prefLabel
Aberrant promoter hypermethyla ...... neck squamous cell carcinoma.
@ast
Aberrant promoter hypermethyla ...... neck squamous cell carcinoma.
@en
P2093
P1476
Aberrant promoter hypermethyla ...... neck squamous cell carcinoma.
@en
P2093
Chun-Yang Fan
Ehab Hanna
Lingbao Si
Sajeev K Puri
P356
10.1016/J.AMJOTO.2004.06.007
P577
2005-01-01T00:00:00Z